Skip to main navigation
Skip to search
Skip to main content
Help & FAQ
Home
Profiles
Organisations
Research output
Grants
Datasets
Prizes / Awards
Engagement / Activities
Press / Media
Units
Equipment
Impacts
Search by expertise, name or affiliation
Safety and tolerability Of Lysyl OxidAse InhibitoR (LOX) In the amelioration of acute and established scAr: a single centre Phase I study
Wood, Fiona
(Chief Investigator)
Fear, Mark
(Investigator 02)
Sandy-Hodgetts, Kylie
(Investigator 03)
UWA Medical School
School of Biomedical Sciences
Overview
Project Details
Status
Active
Effective start/end date
6/11/20
→
6/12/21
Funding
Pharmaxis Ltd:
AUD623,663.00
Pharmaxis Ltd:
AUD76,197.00
View all
View less